These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1521467

  • 1. Induction of experimental autoimmune uveitis with rhodopsin synthetic peptides in Lewis rats.
    Adamus G, Schmied JL, Hargrave PA, Arendt A, Moticka EJ.
    Curr Eye Res; 1992 Jul; 11(7):657-67. PubMed ID: 1521467
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of multiple associative and dissociative proliferative and uveitogenic T-cell sites in human interstitial retinoid-binding protein.
    Merryman CF, Smith N, Donoso LA.
    Curr Eye Res; 1990 Jul; 9 Suppl():97-102. PubMed ID: 1696534
    [Abstract] [Full Text] [Related]

  • 4. Peripheral expression of rod photoreceptor arrestin induces an epitope-specific, protective response against experimental autoimmune uveoretinitis.
    McPherson SW, Roberts JP, Gregerson DS.
    Curr Eye Res; 2005 Jun; 30(6):491-502. PubMed ID: 16020282
    [Abstract] [Full Text] [Related]

  • 5. Analysis of uveitogenic sites in phosducin molecule.
    Satoh N, Abe T, Nakajima A, Ohkoshi M, Koizumi T, Tamada H, Sakuragi S.
    Curr Eye Res; 1998 Jul; 17(7):677-86. PubMed ID: 9678412
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Uveitopathogenic sites in recoverin.
    Ohkoshi M, Abe T, Satoh N, Nakajima A, Sakuragi S.
    Curr Eye Res; 2001 Apr; 22(4):304-11. PubMed ID: 11462170
    [Abstract] [Full Text] [Related]

  • 10. Uveitopathogenic site of the gamma-subunit of cyclic guanosine monophosphate phosphodiesterase in Lewis rats.
    Matsunaga M, Abe T, Satoh N, Nakajima A, Ohkoshi M, Sakuragi S.
    Jpn J Ophthalmol; 2001 Apr; 45(6):570-6. PubMed ID: 11754897
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification of T cell recognition sites in S-antigen: dissociation of proliferative and pathogenic sites.
    Gregerson DS, Fling SP, Obritsch WF, Merryman CF, Donoso LA.
    Cell Immunol; 1989 Oct 15; 123(2):427-40. PubMed ID: 2790968
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oligopeptides of three to five residues derived from uveitopathogenic sites of retinal S-antigen induce experimental autoimmune uveitis (EAU) in Lewis rats.
    Sunil S, Eto K, Singh VK, Shinohara T.
    Cell Immunol; 1993 Apr 15; 148(1):198-207. PubMed ID: 8495487
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. S-antigen. Experimental autoimmune uveitis following immunization with a small synthetic peptide.
    Donoso LA, Merryman CF, Shinohara T, Sery TW, Smith A.
    Arch Ophthalmol; 1987 Jun 15; 105(6):838-40. PubMed ID: 3495256
    [Abstract] [Full Text] [Related]

  • 19. Predominant usage of V beta 8.3 T cell receptor in a T cell line that induces experimental autoimmune uveoretinitis (EAU).
    Egwuagu CE, Bahmanyar S, Mahdi RM, Nussenblatt RB, Gery I, Caspi RR.
    Clin Immunol Immunopathol; 1992 Nov 15; 65(2):152-60. PubMed ID: 1382911
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.